Matthew Pouliot, DO
Pain Medicine · Fort Collins, CONPI 1154584266
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 83.8% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $12,769 and has fallen 72.1% since, to $3,566 in 2025. Among pain medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 370 payments — averaging $69.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Si-bone, Inc.$1K
- Relievant Medsystems, Inc.$1K
- Painteq LLC$322
- Boston Scientific$229
- Stryker$210
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$15,09759%
- Travel & lodging$4,34817%
- Food & beverage$6,10524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 282 | $21,423 |
| Si-bone, Inc. | 12 | $1,287 |
| Relievant Medsystems, Inc. | 8 | $1,056 |
| Painteq LLC | 5 | $322 |
| Boston Scientific | 7 | $229 |
| Stryker | 4 | $210 |
| Abbott | 4 | $147 |
| Saluda Medical Americas, Inc. | 1 | $99 |
| Biodelivery Sciences International, Inc. | 6 | $97 |
| AbbVie | 7 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Nevro Corp. | 4 | $80 |
| Pacira Therapeutics, Inc. | 2 | $51 |
| Tersera Therapeutics LLC | 2 | $43 |
| MDD US Operations, LLC | 3 | $41 |
| Amgen | 3 | $35 |
| Pfizer | 2 | $34 |
| Sentynl Therapeutics, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| SPR Therapeutics, Inc | 1 | $23 |
| Indivior Inc. | 1 | $22 |
| Orexo US, Inc. | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Saol Therapeutics Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$15,129
- Intracept$2,232
- IFUSE IMPLANT SYSTEM$953
- SYNCHROMEDII$410
- PAINTEQ$167
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$131
How this compares
$25,549 in reported general payments places this provider in the 90th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $13,520 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $8,982 |
| Hydromorphone ErHydromorphone Hcl | 11 | $2,098 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $1,524 |
| Celecoxib | 21 | $1,083 |
| Oxycodone Hcl | 57 | $758 |
| Gabapentin | 40 | $530 |
| Testosterone Cypionate | 15 | $516 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $464 |
| Duloxetine Hcl | 17 | $383 |
| Tramadol Hcl | 53 | $296 |
| Tizanidine Hcl | 16 | $138 |
| Methadone Hcl | 12 | $112 |
| Baclofen | 14 | $86 |
| Cyclobenzaprine Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $22 | $13,52018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 96 pain medicine providers in Colorado.
Other pain medicine in Fort Collins
- Charles SissonFort Collins$6K
- Colin CarpenterFort Collins$2K
- Robert MoghimGolden$273K
- Jack RentzGreenwood Village$264K
- Donald BernardiniEnglewood$102K
- Haley BurkeAurora$55K
- Amar PatelThornton$47K
- David ColumbusLoveland$30K
- Justin MerkowEnglewood$24K
- Daniel FeldmanBroomfield$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.